University of Calgary Clinical Trials
Sponsors / University of Calgary
University of Calgary is listed as the lead sponsor on 325 clinical trials registered with ClinicalTrials.gov. 44 trials are actively recruiting participants, 11 remain active without open enrollment, and 138 have concluded. 21 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. The cumulative planned enrollment figure across all listed trials is 188,430 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
325
Total Trials
44
Recruiting
11
Other Active
138
Completed
21
Terminated / Withdrawn
188,430
Total Enrollment
Termination reasons: Other38% · Recruitment38% · Funding10% · Business5% · Efficacy5% · Safety5%
Recent Terminations
- Atrial Fibrillation"we couldn't recruit enough participants"
- Fibromyalgia"Futility criteria met on interim analysis"
- Anterior Cruciate Ligament Injuries"Recruitment stopped due to funding shortage. The scope of the original study increased beyond what had been budgeted in the grant that funded it, and follow-up funding attempts were not successful."
- Gastro-Intestinal Disorder"Manufacturer discontinued the product used for the study: Business decision"
- Optic Neuritis"inability to meet recruitment goals"
- Cicatrix, Hypertrophic"Lack of participants to enroll. Early findings not supportive of fractionated c02 laser improving scars in population studied when used alone."
- Heart Failure"Low accrual rate"
- NCT04095533 Stopped Apr 2020ICU Acquired Weakness"Coronavirus pandemic halted in-unit enrolment and participation"
- Diabetes"During the unavoidable gap resulting from the global pandemic, the technologies being used in this study have significantly improved and it is no longer optimal to provide patients with the old technology when improved technology is availab"
- Sleep Apnea Syndromes"Analysis of initial sample shows negative results."
Active Trials (11 total)
- NCT04259580
- NCT05141916
- NCT06260878
- NCT03214354
- NCT03255408
- NCT04561401
- NCT04829292
- NCT04939623
- NCT04963777
- NCT06367244
- NCT07055373
- NCT03972124
- Stroke PHASE1NCT07469163
- NCT07405450
- NCT06407219
- NCT05283889
- NCT06892847
- NCT07365137
- NCT07348848
- NCT06221358